Inari Medical, Inc. provided earnings guidance for the full year 2024. For the period, the company expects revenue of $592.5 million to $602.5 million, reflecting growth of approximately 20% to 22% over 2023, and a raise versus the prior 2024 revenue guidance of $580 million to $595 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.39 USD | +2.76% |
|
+6.73% | -20.84% |
Jul. 01 | Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 3000E Value Index | CI |
Jul. 01 | Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 3000 Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.84% | 2.99B | |
+75.67% | 12.57B | |
-28.01% | 7.02B | |
+10.01% | 5.24B | |
-18.23% | 4.76B | |
+15.57% | 4.11B | |
-22.78% | 3.74B | |
-1.24% | 2B | |
+12.39% | 1.81B | |
-4.11% | 1.72B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Provides Earnings Guidance for the Full Year 2024